Invivyd, Inc. Files 8-K on Officer/Director Changes
Ticker: IVVD · Form: 8-K · Filed: Mar 26, 2025 · CIK: 1832038
| Field | Detail |
|---|---|
| Company | Invivyd, INC. (IVVD) |
| Form Type | 8-K |
| Filed Date | Mar 26, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: leadership-change, officer-appointment, director-election
Related Tickers: IVVD
TL;DR
Invivyd's 8-K shows leadership changes and officer compensation details.
AI Summary
Invivyd, Inc. filed an 8-K on March 26, 2025, reporting on events as of March 22, 2025. The filing covers the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements for certain officers. It also includes Regulation FD disclosures and financial statements/exhibits.
Why It Matters
This filing indicates potential shifts in the company's leadership and governance structure, which could impact strategic direction and operational oversight.
Risk Assessment
Risk Level: medium — Changes in directors or officers can signal internal shifts that may affect company strategy or stability.
Key Players & Entities
- Invivyd, Inc. (company) — Registrant
- Adagio Therapeutics, Inc. (company) — Former company name
FAQ
What specific officer or director positions were affected by the changes reported in this 8-K?
The filing indicates changes related to 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers,' but the specific names and roles are not detailed in the provided text.
When was the earliest event reported in this 8-K?
The earliest event reported in this 8-K was on March 22, 2025.
What is Invivyd, Inc.'s principal executive office address?
Invivyd, Inc.'s principal executive offices are located at 1601 Trapelo Road, Suite 178, Waltham, MA 02451.
What was Invivyd, Inc.'s former company name?
Invivyd, Inc.'s former company name was Adagio Therapeutics, Inc.
What are the key items covered in this 8-K filing?
This 8-K filing covers the departure of directors or certain officers, election of directors, appointment of certain officers, compensatory arrangements of certain officers, Regulation FD disclosures, and financial statements and exhibits.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 26, 2025 regarding Invivyd, Inc. (IVVD).